文献速递免疫规划

表达马立克氏病病毒糖蛋白B的重组新城疫病毒显著保护鸡抵御马立克氏病病毒和新城疫病毒攻击

Newcastle disease virus (NDV) recombinant expressing Marek's disease virus (MDV) glycoprotein B significantly protects chickens against MDV and NDV challenges.
PubMed 文献 · Vaccine · 2023-08-17

本研究利用反向遗传技术构建了4株表达马立克氏病病毒(MDV)糖蛋白gB、gC、gE或gI的重组新城疫病毒(NDV)LaSota疫苗株,经鼻内和眼内途径接种来航鸡后,表达MDV gB的重组病毒rLS/MDV-gB在接种后14天攻毒时显著保护鸡抵抗MDV诱导的肿瘤形成,所有4株重组病毒均对强毒NDV攻击提供完全保护。

要点

  • rLS/MDV-gB在接种后14天攻毒时显著保护鸡抵抗MDV诱导的肿瘤形成,5天时保护中等。
  • 其余三株重组病毒对MDV攻毒保护力很弱。
  • 所有4株重组病毒均对强毒NDV攻击提供完全保护。

核心结论

  • rLS/MDV-gB病毒是安全有效的双价疫苗候选株,可冻干并可能通过气溶胶或饮水以极低成本大规模接种于大群鸡。

研究设计与样本

  • 利用反向遗传技术构建4株表达MDV糖蛋白gB、gC、gE或gI的重组NDV LaSota疫苗株。
  • 在来航鸡(15I5x71 F1杂交系)中经鼻内和眼内途径接种重组病毒,评估对强毒MDV和NDV攻击的保护效果。

主要发现

  • 重组病毒在体内略有减毒,但在体外与亲本LaSota病毒生长动力学和病毒滴度相似。
  • rLS/MDV-gB在接种后14天攻毒时显著保护鸡抵抗MDV诱导的肿瘤形成,5天时保护中等。
  • 其余三株重组病毒对MDV攻毒提供很少保护。
  • 所有4株重组病毒均对强毒NDV攻击提供完全保护。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Marek's disease (MD) is a highly contagious viral neoplastic disease of chickens caused by Marek's disease virus (MDV), resulting in significant economic losses to the poultry industry worldwide. The commonly used live and/or vectored MDV vaccines are expensive to produce and difficult to handle due to the requirement of liquid nitrogen for manufacturing and delivering frozen infected cells that are viable. In this study, we aimed to develop a Newcastle disease virus (NDV) vectored MDV vaccine that can be lyophilized, stored, and transported at 4 °C. Four NDV LaSota (LS) vaccine strain-based recombinant viruses expressing MDV glycoproteins gB, gC, gE, or gI were generated using reverse genetics technology. The biological assessments showed that these recombinant viruses were slightly attenuated in vivo yet retained similar growth kinetics and virus titers in vitro compared to the parental LaSota virus. Vaccination of leghorn chickens (Lines 15I5x71 F1 cross) with these recombinant viruses via intranasal and intraocular routes conferred different levels of protection against virulent MDV challenge. The recombinant expressing the MDV gB protein, rLS/MDV-gB, protected vaccinated birds significantly against MDV-induced tumor formation when challenged at 14 days post-vaccination (DPV) but moderately at 5 DPV. Whereas the other three recombinants provided little protection against the MDV challenge. All four recombinants conferred complete protection against the velogenic NDV challenge. These results demonstrated that the rLS/MDV-gB virus is a safe and efficacious dual vaccine candidate that can be lyophilized and potentially mass-administered via aerosol or drinking water to large chicken populations at a meager cost.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. He L, Spatz S, Dunn JR, et al. Newcastle disease virus (NDV) recombinant expressing Marek's disease virus (MDV) glycoprotein B significantly protects chickens against MDV and NDV challenges. Vaccine. 2023. PMID: 37598026. doi:10.1016/j.vaccine.2023.08.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。